XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 Latest Research
 Infectious Diseases
 Respiratory Medicine
 Public Health
 Clinical Trials
 Medical News
 Awards & Prizes
 Special Topics
 Odd Medical News
 World News

Last Updated: Aug 19th, 2006 - 22:18:38

Orthopedics Channel
subscribe to Orthopedics newsletter

Latest Research : Orthopedics

   DISCUSS   |   EMAIL   |   PRINT
ACVR1 Gene Responsible for Fibrodysplasia ossificans progressiva (FOP)
Apr 25, 2006, 20:35, Reviewed by: Dr. Priya Saxena

The discovery of the single gene offers new hope of a first effective therapy for the disorder, they said.

Scientists have identified a gene that turns muscle into bone - one of the rarest disorders that affects about one in two million individuals.

The disease named by scientists as Fibrodysplasia ossificans progressiva (FOP) is a connective tissue disorder in which bone grows in tendons, ligaments, and muscles. It begins early in childhood and has no cure.

Researchers led by Frederick Kaplan at the University of Pennsylvania first established that the FOP is likely to be caused by a mutated gene that affects bone morphogenetic proteins (BMPs), which control the formation and repair of the skeleton.

This insight led them to a gene called ACVR1, which controls one of the three main receptors for BMP that determine how cells respond to its signals, the online edition of The Times reported.

In patients with FOP, a tiny mutation in one of the two copies of the ACVR1 gene changes the meaning of its genetic message, so a faulty protein is made, it said.

The discovery of the single gene offers new hope of a first effective therapy for the disorder, they said.

By providing insights into the genetic signals that govern bone growth, the research should also improve understanding and treatment of a wide range of more common skeletal conditions. These include osteoporosis, spinal injuries and sports injuries.

In the longer term, it could also allow scientists to make bone in the laboratory, for treating fractures that fail to heal and skeletal malformations.

- Indo-Asian News Service

Subscribe to Orthopedics Newsletter
E-mail Address:


Related Orthopedics News

Modifying NFATc1 Triggers Bone Production
'Magic formula' accurately predicts fracture risk in osteoporotic women
Calcium supplements fail to prevent bone fractures in children
Estrens might not be the answer for osteoporosis
Increasing NFATc1 activity causes massive bone accumulation
Second-Hand Smoke, First-Hand Problem
Using gene therapy to accelerate damaged muscle regeneration
Low carbohydrate diet did not increase bone loss
Teriparatide to be tested for osteogenesis imperfecta
A novel vertebroplasty technique strengthens vertebrae after removing spinal tumors

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page


© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us